A new study suggests that one of them, ubrogepant (Ubrelvy), may help people stop a migraine attack from happening when it’s used before the pain begins. A migraine attack is a complex ...
According to the medical journal Neurology, researchers said those who took ubrogepant or Ubrelvy were more than 70 per cent likely to function normally within a couple of hours. The drug was also ...
AbbVie Inc. ABBV reported adjusted earnings of $3.00 per share for the third quarter of 2024, beating the Zacks Consensus Estimate of $2.92. The reported earnings also exceeded the company’s ...